CompanyGraph
What stands out
- Pays more per share than it earned over the last twelve months
At a glance
- Depends onDownstream position: depends on 11 industries, supplies 6
- ScaleMarket cap is $368.94B, higher than 95% of all stocks globally
- FinancialsAltman Z-Score 4.52: safe zone
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
What stands out
- Pays more per share than it earned over the last twelve months
Dividends view
Yield
2.27%Below 5Y avg (3.01%)
Annual Rate
USD 3.40Paid quarterly
Payout Ratio
268.8%High
Consecutive Growth
15 yrStrong track record
Paying Dividends
27 yr
Payback Period
43.7 yr
Last Ex-Dividend
Sep 15, 2026
Next Payment
Oct 7, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
368.94BUSDvs all stocks (USD)
Trailing P/E
118.68xRevenue (TTM)
66.57BUSDvs all stocks (USD)
Profit Margin
4.77%Beta
0.2110xvs all stocks
52-Week Change
79.71%vs all stocks
Forward Annual Dividend Yield
2.27%vs all stocks
Market Capitalization
368.94BUSDvs all stocks (USD)
Enterprise Value
415.76BUSDvs all stocks (USD)
Trailing P/E
118.68xForward P/E
15.67xPEG Ratio
-0.9089xPrice to Sales (TTM)
5.54xPrice to Book (MRQ)
8.80xEnterprise to Revenue
6.25xEnterprise to EBITDA
14.40xGross Margin
73.54%Profit Margin
4.77%Operating Margin
-0.24%Return on Assets (TTM)
11.87%Return on Equity (TTM)
6.96%Revenue (TTM)
66.57BUSDvs all stocks (USD)
Revenue per Share (TTM)
26.85USDUpdated Aug 28, 2026Quarterly Revenue Growth
5.10%Gross Profit (TTM)
50.53BUSDvs all stocks (USD)
EBITDA (TTM)
29.11BUSDvs all stocks (USD)
Net Income (TTM)
3.17BUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
5.07%Operating Cash Flow (TTM)
19.97BUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
15.17BUSDvs all stocks (USD)
Forward Annual Dividend Rate
3.40USDUpdated Aug 28, 2026Forward Annual Dividend Yield
2.27%vs all stocks
Trailing Annual Dividend Rate
3.36USDUpdated Aug 28, 2026Trailing Annual Dividend Yield
2.25%vs all stocks
5-Year Average Dividend Yield
3.01%vs all stocks
Payout Ratio
268.80%Minority Interest (Equity)
56.00MUSDFY2025 · Dec 31, 2025Revenue
65.01BUSDFY2025 · Dec 31, 2025Cost of Goods Sold
16.38BUSDFY2025 · Dec 31, 2025Gross Profit
48.63BUSDFY2025 · Dec 31, 2025Operating Income
22.11BUSDvs all stocks (USD)
Pre-tax Income
21.07BUSDFY2025 · Dec 31, 2025Income Tax Expense
2.80BUSDFY2025 · Dec 31, 2025Net Income
18.26BUSDFY2025 · Dec 31, 2025EBIT
22.42BUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
29.11BUSDFY2025 · Dec 31, 2025Research & Development
15.79BUSDFY2025 · Dec 31, 2025Selling, General & Administrative
10.73BUSDFY2025 · Dec 31, 2025Non-operating Interest Income
343.00MUSDFY2025 · Dec 31, 2025Non-operating Interest Expense
1.36BUSDFY2025 · Dec 31, 2025EPS (Basic)
7.38USDFY2025 · Dec 31, 2025EPS (Diluted)
7.28USDFY2025 · Dec 31, 2025Basic Shares Outstanding
2.47BSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
2.47BSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
18.26BUSDFY2025 · Dec 31, 2025Minority Interests (P&L)
-9.00MUSDFY2025 · Dec 31, 2025Operating Cash Flow
18.49BUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
14.69BUSDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
18.26BUSDFY2025 · Dec 31, 2025Depreciation & Amortization
5.84BUSDFY2025 · Dec 31, 2025Deferred Taxes (CF)
-1.67BUSDFY2025 · Dec 31, 2025Stock-based Compensation
820.00MUSDFY2025 · Dec 31, 2025Other Non-cash Items
511.00MUSDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-1.09BUSDFY2025 · Dec 31, 2025Change in Accounts Payable (CF)
110.00MUSDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-4.29BUSDFY2025 · Dec 31, 2025Net Acquisitions
-10.04BUSDFY2025 · Dec 31, 2025Purchase of Investments
-1.21BUSDFY2025 · Dec 31, 2025Sale of Investments
1.68BUSDFY2025 · Dec 31, 2025Other Investing Activity
-58.00MUSDFY2025 · Dec 31, 2025Net Investing Cash Flow
-9.63BUSDFY2025 · Dec 31, 2025Long-term Debt Issuance
13.88BUSDFY2025 · Dec 31, 2025Long-term Debt Payments
-2.50BUSDFY2025 · Dec 31, 2025Common Stock Repurchase
-5.08BUSDFY2025 · Dec 31, 2025Common Dividends Paid
-8.18BUSDFY2025 · Dec 31, 2025Other Financing Charges
-131.00MUSDFY2025 · Dec 31, 2025Net Financing Cash Flow
-2.01BUSDFY2025 · Dec 31, 2025Shares Outstanding
2.47BSharesUpdated Aug 28, 2026Float Shares
2.46BSharesUpdated Aug 28, 2026Shares Short
24.51MSharesUpdated Aug 28, 2026Short Ratio
2.80daysvs all stocks
Short % of Shares Outstanding
0.99%vs all stocks
% Held by Insiders
0.06%vs all stocks
% Held by Institutions
82.71%vs all stocks
Total Cash (MRQ)
7.14BUSDvs all stocks (USD)
Total Cash per Share (MRQ)
2.89USDUpdated Aug 28, 2026Total Debt (MRQ)
53.91BUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
1.28xCurrent Ratio (MRQ)
1.32xBook Value per Share (MRQ)
16.99USDUpdated Aug 28, 2026Total Assets
136.87BUSDvs all stocks (USD)
Total Current Assets
43.52BUSDFY2025 · Dec 31, 2025Total Liabilities
84.20BUSDFY2025 · Dec 31, 2025Total Non-current Assets
93.35BUSDFY2025 · Dec 31, 2025Total Non-current Liabilities
55.88BUSDFY2025 · Dec 31, 2025Total Current Liabilities
28.33BUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents
14.56BUSDFY2025 · Dec 31, 2025Other Short-term Investments
0.00USDFY2025 · Dec 31, 2025Accounts Receivable
11.78BUSDFY2025 · Dec 31, 2025Inventory
6.66BUSDFY2025 · Dec 31, 2025Accounts Payable
4.40BUSDFY2025 · Dec 31, 2025Short-term Debt
2.59BUSDFY2025 · Dec 31, 2025Long-term Debt
46.75BUSDFY2025 · Dec 31, 2025Other Non-current Liabilities
7.69BUSDFY2025 · Dec 31, 2025Common Stock (Book)
1.79BUSDFY2025 · Dec 31, 2025Retained Earnings
73.08BUSDFY2025 · Dec 31, 2025Total Shareholders' Equity
52.66BUSDvs all stocks (USD)
Treasury Stock
63.00BUSDFY2025 · Dec 31, 202552-Week Low
77.58USDUpdated Aug 28, 202652-Week High
156.92USDUpdated Aug 28, 202652-Week Change
79.71%vs all stocks
Beta
0.2110xvs all stocks
50-Day MA
130.11USDUpdated Aug 28, 2026200-Day MA
116.33USDUpdated Aug 28, 2026Avg 10-Day Volume
13.68MSharesUpdated Aug 28, 2026Avg 30-Day Volume
10.25MSharesUpdated Aug 28, 2026Diluted EPS (TTM)
1.26USDUpdated Aug 28, 2026Other Income / Expense
-26.00MUSDFY2025 · Dec 31, 2025Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
Pays more per share than it earned over the last twelve monthsSignificant
Payout Ratio: 2.69Dividend per Share: 3.36Earnings per Share: 1.26
High gross margins eroded by operating costsNotable
Gross Margin: 0.74Profit Margin: 0.05
Financial Health
Altman Z-Score 4.52: safe zoneNotable
Altman Z-Score: 4.52
Supply Chain
Downstream position: depends on 11 industries, supplies 6Notable
Outgoing: 6.00Incoming: 11.00
High connectivity hub: 17 industry connectionsNotable
Total Connections: 17.00
Scale
Market cap is $368.94B, higher than 95% of all stocks globallySignificant
Market cap (USD): 368,940,822,074Global P95: 26,266,743,019.727
Revenue is $66.57B, higher than 95% of all stocks globallySignificant
Revenue (USD): 66,568,998,912Global P95: 15,102,391,082.578
Levered free cash flow is $15.17B, higher than 95% of all stocks globallySignificant
Levered free cash flow (USD): 15,171,500,032Global P95: 1,235,239,084.501
Companies that share the same coordination system — how they create, deliver, or capture value.
Roche Holding AG Genussscheine
Tier 1ProductionApproval-Gated PipelineRuleRisk
AbbVie Inc.
Tier 1ProductionApproval-Gated PipelineRule
Novartis AG
Tier 1ProductionApproval-Gated PipelineRuleRisk
AstraZeneca PLC
Tier 1ProductionApproval-Gated PipelineRuleFlow
Amgen Inc.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Johnson & Johnson
Tier 1ProductionApproval-Gated PipelineRuleFlow
Abbott Laboratories
Tier 1ProductionApproval-Gated PipelineRuleFlow
Gilead Sciences Inc.
Tier 1ProductionApproval-Gated PipelineRule
Pfizer Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Novo Nordisk A/S
Tier 1ProductionApproval-Gated PipelineRule